Du är här

2015-08-18

Omnicare: Omnicare Announces Conversion Rate Adjustments for Convertible Notes

CINCINNATI, August 18, 2015
- Omnicare, Inc. (the "Company") announced today an adjustment to the
conversion rate of its (i) 3.75% Convertible Senior Subordinated Notes due
2025 (the "2025 Notes"), (ii) 3.50% Convertible Senior Subordinated Notes due
2044 (the "2044 Notes"), (iii) 3.25% Convertible Senior Debentures due 2035
(the "Debentures") and (iv) 3.25% Convertible Senior Exchange Debentures due
2035 (the "Exchange Debentures" and, together with the Debentures, the "2035
Debentures"). Effective August 18, 2015, the adjusted conversion rate for (i)
the 2025 Notes is 37.7191 shares of common stock per $1,000 principal amount,
(ii) the 2044 Notes is 14.3863 shares of common stock per $1,000 principal
amount, provided, that, the conversion rate with respect to any conversions
"in connection with" the Non-Stock Change of Control, as defined in the
applicable indenture, is 15.2307 and (iii) the 2035 Debentures is 13.0483
shares of common stock per $1,000 principal amount; provided, that, the
conversion rate with respect to any conversions "in connection with" the
Non-Stock Change of Control, as defined in the applicable indenture, is
13.1278.

The conversion rates were initially adjusted in connection with the Company's
regular quarterly dividend payments. The further adjustments to the
conversion rates "in connection with" the Non-Stock Change of Control, are in
connection with the consummation of the transactions contemplated by the
Agreement and Plan of Merger, dated as of May 20, 2015, by and among the
Company, CVS Pharmacy, Inc., a Rhode Island corporation ("CVS Pharmacy"), and
Tree Merger Sub, Inc. ("Merger Sub"), a Delaware corporation and wholly owned
subsidiary of CVS Pharmacy, pursuant to which Merger Sub merged with and into
the Company, with the Company continuing as the surviving company and a
wholly owned subsidiary of CVS Pharmacy.

About Omnicare

Omnicare, Inc., a wholly owned subsidiary of CVS Health Corporation, provides
comprehensive pharmaceutical services to patients and providers across the
United States. As the market-leader in professional pharmacy, related
consulting and data management services for skilled nursing, assisted living
and other chronic care institutions, Omnicare leverages its unparalleled
clinical insight into the geriatric market along with some of the industry's
most innovative technological capabilities to the benefit of its long-term
care customers. Omnicare also provides specialty pharmacy and key
commercialization services for the bio-pharmaceutical industry through its
Specialty Care Group. For more information, visitwww.omnicare.com.

# # #

Contact:

Patrick C. Lee
(513) 719-1507
patrick.lee@omnicare.com

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Omnicare via Globenewswire

HUG#1946363

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.